Novo Nordisk will issue its fifth round of refunds this year on prices charged to 340B providers. The latest are [...] …
Articles by : Rich Daly, Editor in Chief
Months after it was expected, bipartisan legislation to prevent drugmaker restrictions on the use of contract pharmacies by 340B providers [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical company executives discussed a range of 340B-related developments in recent third quarter investor calls. An executive for BioMarin Pharmaceutical, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
U.S. Public Health Service Lieutenant Commander Emeka Egwim left his position as director of the federal office overseeing the 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The fifth and final fiscal year 2023 manufacturer audit by federal officials recently concluded with no adverse findings. Meanwhile, the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal auditors determined terminations from the 340B program were required for either covered entity sites or contract pharmacies of four [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Biopharmaceutical manufacturer Biogen recently expanded its contract pharmacy restrictions for hospitals to a third drug, after that medication garnered a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B program has become “a multibillion-dollar boondoggle for hospital mega-chains” and needs reform, says Howard Dean, a one-time Democratic [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A congresswoman who has led legislative initiatives to bolster provider access to the 340B program was among 12 members of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A center-left group that has received pharmaceutical industry funding is urging a series of 340B reforms that it hopes to [...] …
